Session: Novel Pathways and Approaches in Allergic Disease

Repurposing Approved Bruton’s Tyrosine Kinase Inhibitors for the Prevention of Anaphylaxis

Wednesday, June 19, 2024

8:00 AM – 8:30 AM PT

Location: Salon 8

Speaker(s)

Melanie C. Dispenza, MD, PhD

Assistant Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States

Disclosure(s):

Melanie C. Dispenza, MD, PhD: No relevant disclosure to display

Describe published data using BTK inhibitors to prevent anaphylaxis in humans
Describe safety data for newer-generation BTK inhibitors
Identify gaps in knowledge related to using BTK inhibitors in allergic disorders